PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PharmaJet, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Co-Founders of PharmaJet Honored as Laureate of The Tech Museum’s Tech Awards in 2010 - (Laureate) is One of 15 Innovators from Around the World Recognized for Applying Technology to Benefit Humanity
Co-Founders of PharmaJet Honored as Laureate of The Tech Museum’s Tech Awards in 2010


NewswireToday - /newswire/ - Golden, CO, United States, 2010/10/01 - (Laureate) is One of 15 Innovators from Around the World Recognized for Applying Technology to Benefit Humanity.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Kathleen Callender and Heather Callender-Potters, founders of PharmaJet, Inc. (proprietary needle-free jet injection technology used to deliver vaccines) were this week named to The Tech Awards Laureates 2010, as one of 15 global innovators recognized each year for applying technology to benefit humanity and spark global change. The Tech Awards, a signature program of The Tech Museum, and presented by Applied Materials, Inc., selected them from among hundreds of nominations representing more than 50 countries.

About the Tech Awards
Technology Benefiting Humanity is one of the premier annual humanitarian awards programs in the world, recognizing technical solutions that address the most critical issues facing our planet and its people. The awards program honors 15 scientists and innovators annually alongside the recipient of the Global Humanitarian Award, which will be presented this year to Queen Rania Al Abdullah of Jordan. Laureates are selected by a prestigious panel of international judges organized by the Center for Science, Technology, and Society at Santa Clara University, and made up of Santa Clara University faculty as well as leaders from educational and research institutions, industry and the public sector around the world.

Established in 2000, The Tech Awards recognizes 15 laureates, three in each of five universal categories: education, equality, environment, economic development and health. These laureates have developed new technological solutions or innovative ways to use existing technologies to significantly improve the lives of people around the world. This year, the laureate list represents the truly global vision of the program, including individuals from Brazil, Bangladesh, the Philippines and the San Francisco Bay Area. The laureates work impacts people in many more countries worldwide. One laureate in each category will receive a $50,000 cash prize during the annual Awards Gala in Santa Clara, California on November 6.

About the founders
With her hands-on healthcare and practice management background, Ms. Callender has participated in medical group missions work in the developing world, which is where she witnessed first-hand the profound problems of needle re-use and needle-stick injuries. A dirty needle can transmit up to 20 blood borne pathogens, most commonly HIV, Hepatitis B, and Hepatitis C. There are an estimated 22 million needle-stick injuries world-wide per year; and the WHO estimates that up to 40-70% of needles are re-used in some countries. PharmaJet’s technology has been propelled by Kathy’s passion to make a difference in global world health by increasing the vaccination of the worlds children while at the same time limiting the source of needle re-use related diseases that plague the developing world and negatively impact the livelihood of so many individuals, their families and communities.

A private equity fund manager and active angel investor, Ms. Callender-Potters is also passionate about the advancement of technologies that can create a paradigm shift in thinking and application. Heather spent 19 years investing in early stage businesses in Central and Eastern European countries, helping to introduce novel technologies that can flourish and contribute to the health of emerging economies. She has worked to advance PharmaJet’s collaborations that will have a great impact on both the developed and the developing world. In particular, her focus has been on the company’s intra-dermal injection technology that has the ability to positively impact the body’s immune response several fold versus standard depth of injection used by traditional needle-syringe.

“We are extremely honored to be among the Tech Awards recipients, and are so pleased that the award festivities and community of contributors will allow us a unique avenue for further advancing our dream to make a positive change in world health,” said Heather Callender-Potters, Chairman of PharmaJet. Kathleen Callender added, “each time I find a kindred spirit who shares my passion for making a difference, especially for the young children of the developing world, I am inspired to work harder toward my goal of contributing to world health. Being included in the Tech Awards organization is not only rewarding, but constitutes an obligation for me to continue my efforts toward having PharmaJet’s needle-free technology widely used as a solution to improve the overall well being of people worldwide.”

About PharmaJet, Inc. and needle-free injections
PharmaJet’s needle-free technology ( delivers vaccines to intra-muscular, subcutaneous, and intra-dermal tissue depths. For some vaccines, intra-dermal delivery has the potential to reduce the amount of vaccine required, in some cases by as much as 80%, leading to cost savings and expanded coverage for vaccines in limited supply. Previous generations of jet injectors delivered billions of doses of vaccines over the last 60 years, but they had undesirable features, such as pain, cross-contamination among patients, low durability, and the ability for disposable components to be re-used. Newer devices, like PharmaJet's system, have been well received in the developed world, but are also more appropriate for the developing world because of their usability, affordability, and improved safety features (by design, PharmaJet’s “needle-free” syringe cannot be reused).
Needle-free jet injection also has the potential to improve safety by eliminating needles from the process of administering vaccines, and eliminating sharps (used metal needle’s) from the environment. “Jet” injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses of medications and vaccines while reducing the burden of hazardous waste management. The potential benefits of jet injectors include more consistent delivery, reduced vaccine wastage, elimination of the need to transport large volumes of sharps, and reduction of the risk of needle sticks and of the costs associated with sharps waste.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: PharmaJet, Inc.


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Co-Founders of PharmaJet Honored as Laureate of The Tech Museum’s Tech Awards in 2010

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Regina Todd - 
410-209-2389 todd[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PharmaJet, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From PharmaJet, Inc. / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  NAKIVO, Inc.

  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (